Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Immunotherapy

The adverse events of toripalimab in nasopharyngeal carcinoma based on FAERS database and bibliometric analysis

Qian Guo, Dong Dong, Zihan Dang, Shuman Huang, Xinjie Qiao, Baiquan Zhang, Yulin Zhao

published 20 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Exploration of predictive factors based on oral and intestinal bacterial flora for treating patients with urothelial carcinoma

Yuichi Matsumoto, Yukihiro Hitaka, Hiroshi Hirata, Yoshiaki Yamamoto, Keita Kobayashi, Naohito Isoyama, Toshio Matsubara, Kenji Watanabe, Yoichi Mizukami, Shin Nakagawa, Katsuaki Mishima, Koji Harada, Koji Shiraishi

published 18 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Understanding the combined symptom medication score in the light of contexts and mechanisms

Anne Møller Lohmann, Anne Poder Petersen, Johannes Martin Schmid, Hans Jürgen Hoffmann, Jeanette Finderup

published 16 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Prognostic impact of HER2-low expression in triple-negative breast cancer of high-grade special histological type and no special type

Claudia Grosse, Petar Noack, Alexandra Grosse, Heike Kathleen Schwarz, Peter Schrenk, Heike Frauchiger-Heuer, Rupert Langer, Zsuzsanna Varga

published 13 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Multi-omics analysis and single-cell sequencing revealed the lysosome associated molecular subtypes and prognostic model development of papillary thyroid carcinoma

Jianhua Zhang, Kai Yue, Yansheng Wu, Chao Jing, Xudong Wang

published 10 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Combining CD3/GD2 bispecific T cell engager with human Vγ9Vδ2 T cells facilitates neuroblastoma cell targeting and killing in vitro

Kuntida Kitidee, Sumet Amonyingcharoen, Sarinthip Preedagasamzin, Korakot Atjanasuppat, Piamsiri Sawaisorn, Pornprapa Srimorkun, Sawang Petvises, Wanpen Chaicumpa, Suparerk Borwornpinyo, Usanarat Anurathapan, Suradej Hongeng

published 09 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Agent-based modeling for personalized prediction of an experimental immune response to immunotherapeutic antibodies

Omri Matalon, Andrea Perissinotto, Kuti Baruch, Shai Braiman, Anat Geiger Maor, Eti Yoles, Ella Wilczynski, Uri Nevo, Avner Priel

published 09 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma

Chengting Wu, Xinyuan Chen, Yu Zhang, Yuanqin Du, Jian Xu, Yujiao Peng, Lu Lu, Jingjing Huang, Hongna Huang

published 04 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Correlation analysis of mitochondrial DNA maintenance-related genes with HCC prognosis, tumor mutation burden and tumor microenvironment features

Fan Rong, Bin Cheng, Ling Guo, Shaobo Zeng, Xunliang Xu, Zhongji Meng

published 02 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Hepatotoxicity of ICI monotherapy or combination therapy in HCC: A systematic review and meta-analysis

Yuping Lu, Jing Lin, Yufeng Lu, Luping Lin, Shicheng Zheng, Yu Chen, Sha Huang

published 29 May 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Identification of a novel chemotherapy benefit index for patients with advanced ovarian cancer based on Bayesian network analysis

Shuxiao Ma, Lu Zhou, Yi Liu, Hui Jie, Min Yi, Chenglin Guo, Jiandong Mei, Chuan Li, Lei Zhu, Senyi Deng

published 27 May 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Animal models in preclinical metastatic breast cancer immunotherapy research: A systematic review and meta-analysis of efficacy outcomes

Yalda Mirzaei, Martina Hüffel, Sarah McCann, Alexandra Bannach-Brown, René H. Tolba, Julia Steitz

published 07 May 2025

Loading metrics information...

Metrics unavailable. Please check back later.

C16orf74 is a novel prognostic biomarker and associates with immune infiltration in head and neck squamous cell carcinoma

Xiang-Rong Yao, Fang-Zhu Xiao, Wen-Tao Xiao, Cui-Qin Huang, Jun-Yan He

published 07 May 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Immunotherapy

You can change these options by clicking profile then "Alerts and Notifications"